Overview

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company's commercialized medicines...

Open

$0.00

Prior close

$927.89

Today's high

$0.00

Today's low

$0.00

52 Week high

$974.00

52 Week low

$591.52

News

GlobeNewsWire • 16 hours ago • REGN

Regeneron Announces Investor Conference Presentations

Benzinga • 23 hours ago • REGN

These Analysts Raise Their Forecasts On Regeneron Pharmaceuticals After Upbeat Q3 Results

Benzinga • 23 hours ago • REGN

Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

The Motley Fool • 2 days ago • REGN

Regeneron: 3 Key Takeaways for Long-Term Investors

Zacks Investment Research • 3 days ago • REGN

REGN Q3 Earnings Beat on Dupixent Profits & Eylea HD Growth, Stock Up